Nonselective -blockers, such as propranolol, block both beta-1 and beta-2 adrenergic receptors, while beta-1 selective -blockers, i.e., metoprolol, primarily target beta-1 receptors
Although research is still at an early stage and mostly in animal models, peptides like BPC-157 may provide insight into immune-linked inflammation and healing processes
Skipping doses or not adhering to the prescribed schedule can significantly impact the effectiveness of semaglutide
BPC 157, a pentadecapeptide found in the gastric system or stomach has been demonstrated when supplemented to promote the healing of different tissues, including skin, muscle, bone, ligament and tendons
These studies aim to extend the therapeutic indications of currently approved GLP-1 molecules beyond their established roles in diabetes, obesity and CVD management